Target intelligence / Profile preview

Antioxidant gene expression pathway

Molecular classification
Other (Pathway), Not a single molecule or receptor, Gene expression network/regulatory pathway
01

Overview

The "Antioxidant gene expression pathway" is not a single molecular target but rather refers to a network of genes encoding antioxidant enzymes that regulate cellular responses to oxidative stress. Key members include glutathione peroxidases (GPX1, GPX3, GPX4), superoxide dismutases (SOD1—cytosolic; SOD2—mitochondrial), catalase (CAT), selenoproteins such as SELENOP and SEP15, glutathione reductase (GSR), and transcription factors like NFE2L2. These genes coordinate the detoxification of reactive oxygen species generated during normal metabolism or pathological conditions. Altered expression patterns in this gene set are associated with cancer development/progression,[1][2] immune infiltration,[3] neurodegeneration,[1] cardiovascular diseases,[1] and kidney disorders.[3] The collective activity of these genes serves both as a biomarker panel for disease states and potential targets for therapeutic intervention at the level of individual components rather than as one unified druggable entity. The "Antioxidant gene expression pathway" is best understood as an interconnected regulatory system involving multiple antioxidant enzymes whose coordinated activity maintains redox balance in cells. It is not itself considered a canonical therapeutic target such as an enzyme or receptor but represents an important biological process influencing health and disease outcomes.[4] In summary: The term does not refer to a single molecule/receptor but rather describes a functional group/pathway involving several well-characterized antioxidant proteins.

Other names
Antioxidant pathwayAntioxidant gene signatureAntioxidant enzyme expression pathway
02

Mechanism of action

Mechanisms are diverse and depend on modulation of individual antioxidant enzymes or transcription factors.

03

Biological functions

Regulation of oxidative stress responseCellular redox homeostasisModulation of immune responseProtection against reactive oxygen species (ROS)Tumor progression and metastasis marker
04

Disease associations

Cancer (tumor progression, prognosis, and recurrence)Neurodegenerative diseaseCardiovascular diseaseKidney disease
05

Biomarkers

GPX1, GPX3, SOD1, SOD2, CAT, NFE2L2—expression levels used as biomarkers for tumor progression and prognosis in various cancers

Beyond the preview

Go deeper on Antioxidant gene expression pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant gene expression pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call